H1B Salary Data

Home › Employers › Envisionary Life Health Science LLC

Envisionary Life Health Science LLC: H-1B salaries and sponsorship

Envisionary Life Health Science LLC filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $68,661.

Applications (LCAs)3
Certified3
Employer addressMelville, NY
H-1B dependent employerNo
Median offered salary$68,661
Middle half of salaries$68,661–$68,661
10th–90th percentile$68,661–$68,661

Does Envisionary Life Health Science LLC sponsor H-1B visas?

Envisionary Life Health Science LLC filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 3, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Senior Graphic Designer2$68,661
Information Technology Specialist1—

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20241—
FY20251—
FY20261$68,661

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Senior Graphic Designer$68,661
Level II
Melville, NYApr 3, 2026Apr 15, 2026Certified
Information Technology Specialist$79,331
part-time · Level I
Bayonne, NJSep 9, 2025Oct 1, 2025Certified
Senior Graphic Designer$67,184
part-time · Level II
Melville, NYApr 23, 2024May 6, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).